Drag a card by its title · ⚙ to size, swap or remove

The company

ACADIA Pharmaceuticals Inc.

ACAD · Nasdaq

Health CarePharmaceuticalsNot moving yet

ACAD stood above a rising 150-day average in 24 of the last 52 weekly readings, and has been out of that trend for the last 4 weeks. It is 16.8% below that average now. Pharmaceuticals: 32% of its 74 stocks in an uptrend (−7 points in four weeks); Health Care: 26% (−10 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 4
Industry in uptrend: 32% -7 in 4 wk
Insider buys, 12 months: $0
Insider sales, 12 months: $5.8M
Officials’ trades on record: 4
Institutions holding: 325 (+9)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 24 of 52 weeks.

20 Apr – 19 Oct

Pharmaceuticals: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

4 disclosed lines: House 3, Senate 0, executive 1; 3 people.

Who	Did	Amount	Traded
Donald J. Trump Executive branch: Office of Government EthicsWhite House Office	sold	$15k–$50k	29 Jul 2026filed 22 Sep 2026
Chris Jacobs House: U.S. House ClerkNY27	sold	$1k–$15k	16 Jun 2022filed 28 Jul 2022
Chris Jacobs House: U.S. House ClerkNY27	sold	$1k–$15k	8 Sep 2020filed 6 Nov 2020
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA39	sold	$1k–$15k	19 Feb 2019filed 8 Mar 2019

Insiders

Buy orders, 12 months0

Sale orders, 12 months20

Buyers · sellers0 · 6

Who	Did	Shares	Traded
Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICER	sold	5,000at $29.00	6 Aug 2026filed 7 Aug 2026
Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICER	sold	9,292at $29.34	6 Aug 2026filed 7 Aug 2026
Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICER	sold	5,849at $29.00	5 Aug 2026filed 7 Aug 2026
Elizabeth H.z. ThompsonEVP, Head of Research & Dev	sold	16,508at $26.13	30 Jul 2026filed 31 Jul 2026
Elizabeth H.z. ThompsonEVP, Head of Research & Dev	sold	50at $26.17	30 Jul 2026filed 31 Jul 2026
James KiharaPRINCIPAL ACCOUNTING OFFICER	sold	11,421at $26.08	26 Jun 2026filed 29 Jun 2026
James KiharaPRINCIPAL ACCOUNTING OFFICER	sold	5,401at $21.18	26 May 2026filed 27 May 2026
James KiharaPRINCIPAL ACCOUNTING OFFICER	sold	1,332at $21.79	4 May 2026filed 5 May 2026
Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICER	sold	3,506at $21.79	4 May 2026filed 5 May 2026
James KiharaPRINCIPAL ACCOUNTING OFFICER	sold	1,030at $22.20	7 Apr 2026filed 7 Apr 2026
Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICER	sold	2,709at $22.20	7 Apr 2026filed 7 Apr 2026
James KiharaPRINCIPAL ACCOUNTING OFFICER	sold	1,097at $21.65	26 Mar 2026filed 26 Mar 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders325+9 on the quarter

New · exited47 · 37

Reported value$4.2B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
BAKER BROS. ADVISORS LPadded · filed 14 Aug 2026	42,912,904$1.1B	+16,2140.0%
BlackRock, Inc.added · filed 7 Aug 2026	22,515,173$569.6M	+964,252+4.5%
STATE STREET CORPadded · filed 7 Aug 2026	9,076,212$229.6M	+743,441+8.9%
VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 2026	8,838,450$223.6M	+166,805+1.9%
RTW INVESTMENTS, LPunchanged · filed 14 Aug 2026	7,144,524$180.8M	00.0%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	5,763,750$145.8M	+102,350+1.8%
DIMENSIONAL FUND ADVISORS LPadded · filed 11 Aug 2026	3,694,988$93.5M	+539,828+17.1%
GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026	3,358,129$85.0M	-106,560−3.1%
GOLDMAN SACHS GROUP INCadded · filed 14 Aug 2026	2,580,115$65.3M	+1,022,311+65.6%
Qube Research & Technologies Ltdadded · filed 14 Aug 2026	2,446,610$61.9M	+1,496,311+157.5%